Psychiatrist Dr. Daniel Amen explains how beta blockers work for anxiety by blocking adrenaline effects, as the medication is ...

“Yet at this time, some 80% of patients in the US, Europe and Asia are treated with beta-blockers because medical guidelines still recommend them,” he said. “While we often test new drugs, it’s much ...

On average, an American dies from cardiovascular disease every 34 seconds, reports the American Heart Association (AHA). Furthermore, the AHA observed a nearly 29 percent increase in stroke-related ...

Beta-blockers are relatively common medications used to treat high blood pressure, abnormal heart rhythms, and a range of other conditions. They work by blocking epinephrine (a.k.a. adrenaline), which ...

One way or another, beta blockers are always in the news. Take, for instance, Los Angeles Chargers Head Coach Jim Harbaugh, who revealed in October that he's part of a growing group of Americans who ...

The research found the highest risk with beta-blockers like metoprolol, carvedilol, and nebivolol. They are usually broken ...

A type of drug used to help treat heart attacks does not work on the majority of patients and may actually contribute to hospitalization and death for women, new research has found. However, a study ...

ATLANTA — Beta blockers are a mainstay in cardiovascular treatment, frequently given to patients after heart attacks. But a new large trial turns that convention on its head, suggesting that the drugs ...

The research found that combining the two types of drugs could lower blood pressure by up to 20% and raise the risk of a slow ...

British researchers found that beta-blockers were associated with a reduced risk for primary care consultations for knee osteoarthritis and knee and hip pain. A review of the findings was the top ...

Depression was not more common in patients who used beta-blockers. The rate of discontinuing medications due to depression was the same for people taking beta-blockers compared to people taking other ...

A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn’t benefit the vast majority of patients and may contribute to a higher risk of ...